Ran Nussbaum - 16 Jun 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
16 Jun 2022
Net transactions value
+$11,055
Form type
4
Filing time
28 Feb 2023, 11:21:59 UTC
Previous filing
17 Jun 2022
Next filing
28 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $11,055 +2,211 +0.15% $5.00* 1,437,169 16 Jun 2022 Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -2,211 -100% $0.000000* 0 16 Jun 2022 Ordinary Shares 2,211 $5.00 By Pontifax (Israel) III Limited Partnership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.